Search - tctmd.com

Displaying 521 - 540 of 766

Sort: Relevancy | Date

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Daily News

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

L.A. McKeown

March 08, 2016

News Daily News

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Shelley Wood

March 07, 2016

News Daily News

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Shelley Wood

March 07, 2016

News Daily News

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Shelley Wood

March 07, 2016

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

News Industry News

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

March 06, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

L.A. McKeown

February 21, 2016

News Daily News

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Caitlin E. Cox

January 20, 2016

News Daily News

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

Shelley Wood

January 20, 2016

Advertisement

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content